Skip to content
AwardedPRTGoods

Tisagenlecleucel 1.2 x10e6 - 6 x10e8 células Disp inj Fr 50 ml IV

Published
Published 16 April 2026

Overview

Tisagenlecleucel 1.2 x10e6 - 6 x10e8 células Disp inj Fr 50 ml IV

Key details

Country
PRT
Status
Awarded
Category
Goods
Procedure
Direct
Published
16 April 2026
Classification (CPV)
Pharmaceutical products

Award outcome

Awarded value
€6,318,925
Award date
3 April 2026
Winner
  • Novartis Farma - Produtos Farmacêuticos

Contract ending soon? Skim tracks incumbents and flags recompetes early. Book a demo to set up alerts.

Notice history

Every published notice in this contracting process, newest first.

  1. Contract Award Notice

    16 April 2026

Contracting authority

  • Instituto Português de Oncologia do Porto Francisco Gentil, EPE

    Procuring entity

    PORTO, PRT

Get the full picture

AI analysis, bid scoring, and expert strategy for this tender

Skim analyses every tender against your company profile and tells you whether to bid, how to win, and who you are up against.

See which competitors are winning the contracts you're chasing.

15-minute call. We'll pull the win data on your real pipeline and show you what Skim does with it.

Awarded: Tisagenlecleucel 1.2 x10e6 - 6 x10e8 células Disp inj Fr 50 ml IV — won by Novartis Farma - Produtos Farmacêuticos — Skim